The programme committee consists of a diverse group of experts from academia, industry, and governmental bodies working in the field of drug development and Antimicrobial Resistance (AMR). This combination of profiles and expertise ensures a broad range of perspectives when addressing the development of new antimicrobials and the challenges posed by AMR in the use of existing agents.
Registration for ESCMID Global 2026 in Munich is now open.
Register now to get the early registration fee and attend the world’s most eminent event in the field of infection.